[Form 4] Pagaya Technologies Ltd. Insider Trading Activity
Rhea-AI Filing Summary
Pagaya Technologies insider sale by CFO. Pagaya Technologies Ltd. reporting person Evangelos Perros, identified as the company's Chief Financial Officer and a director, reported two separate dispositions of Class A ordinary shares on September 5 and September 9, 2025. The filings show sales of 9,435 shares on 09/05/2025 at a weighted average price of $38.8376 and 14,356 shares on 09/09/2025 at a weighted average price of $37.3365, for a combined total of 23,791 shares sold.
After these transactions the reporting person beneficially owned 59,079 Class A ordinary shares. The form includes explanations that each sale consisted of multiple transactions within described price ranges and offers to provide detailed per-trade quantities on request. The Form 4 was signed by an attorney-in-fact on 09/09/2025.
Positive
- Transparent disclosure of transaction dates, quantities, weighted average prices, and post-sale beneficial ownership.
- Continued ownership: the reporting person still beneficially owns 59,079 Class A ordinary shares after the reported sales.
Negative
- Insider dispositions: the CFO sold a total of 23,791 Class A ordinary shares across two transactions.
- Price range variability: sales occurred in multiple trades at prices ranging from $37.25 to $39.21, creating some ambiguity about per-trade details (though the filer offers to provide them on request).
Insights
TL;DR Insider sales of 23,791 shares by the CFO are disclosed; holdings remain meaningful at 59,079 shares.
The Form 4 reports routine dispositions by Chief Financial Officer Evangelos Perros totaling 23,791 Class A shares across two dates with weighted average prices of $38.8376 and $37.3365. From an investor-signaling perspective, officer sales are notable but not necessarily unusual; the reporting person retains 59,079 shares after the transactions, indicating continued ownership. The filing notes the sales were executed in multiple trades within stated price ranges and commits to disclosing per-trade quantities if requested, which supports transparency.
TL;DR Disclosure is complete and timely; transactions appear documented without corrective language.
The Form 4 clearly identifies the reporting person, relationship to the issuer, transaction dates, quantities sold, weighted average prices, and post-transaction beneficial ownership. The inclusion of explanatory footnotes about weighted average prices and an attorney-in-fact signature suggests proper procedural handling. There is no information in the filing indicating any noncompliance or an associated Rule 10b5-1 plan; the box indicating a planned sale is not checked. Based on the filing alone, this appears to be a routine reported sale rather than a governance red flag.